Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-23-053819

Options or other derivatives

  • Chief Medical Officer acquired 16,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Morrow Phuong Khanh · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +16,667 16,667 D
Loading xslF345X05/ownership.xml…